Skip to Content
UW Health SMPH
American Family Children's Hospital
SHARE TEXT
George Wilding, MD close
yzurLWdpk7c
George Wilding, MD
 


For Patients

Need help selecting a doctor?
Call the Welcome Center at
(608) 821-4819 for personal assistance.

For Referring Physicians

How to refer a patient

George Wilding, MD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

George Wilding, MD, was named Interim Director in 2002 and was Director of the University of Wisconsin Carbone Cancer Center from 2004 to 2013. A nationally renowned prostate cancer researcher, Wilding is the Donald and Marilyn Anderson professor of medicine. 

 

A native of Everett, Massachusetts, Wilding graduated from the University of Massachusetts Medical School, where he also completed his internship and residency in Internal Medicine. He underwent training in Medical Oncology within the Medicine Branch at the National Cancer Institute. He has a master's degree (pharmacology) from Pennsylvania State University and bachelor's degrees from Tufts University (chemical engineering and biology).

Specialties

Medical Oncology

UW Health Clinics

UW Carbone Cancer Center
(608) 265-1700 | (800) 323-8942 | Map

Hospital Affiliation(s)

University of Wisconsin Hospital and Clinics (primary)

UW School of Medicine and Public Health

Department of Medicine

Professional Certifications and Education

Board Certification Internal Medicine
Medical Oncology
Fellowship National Cancer Institute, NIH, Bethesda, MD
Residency University of Massachusetts Medical School, Worcester
Internship University of Massachusetts Medical School, Worcester
Medical School University of Massachusetts Medical School, Worcester, MA, 1980

Awards/Honors

Best Doctors® in America 2014

Best Doctors® in America 2013

Best Doctors® in America 2011


Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.
Research

In his clinical practice, Wilding sees patients with genitourinary cancers, including prostate, kidney, testicular and bladder cancers. From 1995 to 2003, he directed the UW Carbone Cancer Center Experimental Therapeutics Program, which seeks to identify new anti-cancer agents in the laboratory and translate them into clinical treatments with human patients. He served as chairman of the Genitourinary Cancer Committee of the Eastern Cooperative Oncology Group, a National Cancer Institute (NCI)-sponsored clinical research group for 10 years until 2003, and serves on numerous NCI, industry and foundation advisory and review boards.


PubMed Articles

PubMed articles are currently unavailable.